NIVCD carries out evaluation for passive immunization

In many reports of the clinical trials of passive immunization at various hospitals across the province, the National Institute of Cardiovascular Disease (NIVCD) has become one of six institutes chosen to carry out trials by the Sindh government.

In many reports of the clinical trials of passive immunization at various hospitals across the province, the National Institute of Cardiovascular Disease (NIVCD) has become one of six institutes chosen to carry out trials by the Sindh government.

An initial report was sent to the Sindh Health Department, which revealed that ongoing plasma therapy trials, spearheaded by the National Institute of Blood Disease (NIBD), had achieved an 80 percent success rate in curing Covid-19 patients.

The Sindh government has, so far, permitted six government teaching hospitals in the province to carry out these clinical trials in collaboration with the NIBD. These hospitals include Dr. Ruth Pfau Civil Hospital Karachi, Jinnah Postgraduate Medical Centre, Shaheed Benazirabad Peoples University of Medical and Health Sciences for Women, Sukkur Ghulam Muhammad Mahar Medical College and the NICVD.

These clinical trials, which were based on three patients chosen from across the nation, were initially approved by the Drug Authority of Pakistan.

The trials are being conducted under the supervision of NIBD chairperson and dean Dr. Tahir Shamsi, while the assistant investigators include Lahore University of Health Science vice-chancellor Prof Dr. Javed Akram and Liaquat University of Medical and Health Sciences vice-chancellor Prof Dr. Bekha Ram. Meanwhile, NIBD’s Prof Dr. Arshi Naz is the national focal person for the trials.

The passive immunization trials have also been registered with the World Health Organisation and the United States National Institute of Health.

 

Leave a Reply

Your email address will not be published. Required fields are marked *

Captcha loading...